S3-E42 — Allied Health and Patient Empowerment for NAFLD
Send us Fan Mail Surfers Louise Campbell and Jörn Schattenberg are joined by patient advocate Robert Mitchell-Thain, liver nurse Michelle Clayton, and healthcare consultant Stephen Callaghan to talk a...
25 Elo 20221h 4min
S3-E41.6 - From the Vault: Why NASH Drug Trials Fail
Send us Fan Mail Jörn speaks about co-authoring an article, “The Nonalcoholic Steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future successes.” In doing so, he...
21 Elo 202217min
S3-E41.5 - Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
21 Elo 202212min
S3-E41.4 - Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
21 Elo 202212min
S3-E41.3 - Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
20 Elo 202212min
S3-E41.2 - Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
20 Elo 202213min
S3-E41.1 - Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
20 Elo 202212min
S3-E41- Improving NASH Clinical Trials By Reducing Screen Fail Rates
Send us Fan Mail THE NASH Tsunami audience came to know Jörn Schattenberg in the Fall of 2020 when he shared a paper he had recently co-authored on why NASH drug trials failed. This week, the same gro...
18 Elo 20221h 3min
